Loudon J R, McGarrity G, Vallance R, Baylis A C, Graham J
Br J Surg. 1978 Sep;65(9):616-8. doi: 10.1002/bjs.1800650909.
The fibrinogen uptake test has been used to detect deep vein thrombosis after total hip replacement in 90 patients. The upper third of the thigh in each leg was ignored and peripheral leg counting carried out distal to this. The results were directly compared with the findings of venography in the 170 legs of the 90 patients. There was a high false positive rate (30 per cent) with the fibrinogen uptake test which was associated with the presence of the knee joint effusion or varicose veins, but not with the site of operation. There was a low false negative rate (less than 5 per cent), and the fibrinogen uptake test, used in this way, may fail to detect a percentage of small thrombi in the wound area that are probably produced by the local trauma of operation. It is considered that the fibrinogen uptake test has a clinical use as a screening test for deep vein thrombosis after hip replacement, but venography is required in the interests of accuracy.
纤维蛋白原摄取试验已被用于检测90例全髋关节置换术后的深静脉血栓形成。每条腿大腿上三分之一部分被排除在外,在其远端进行腿部外周计数。结果与90例患者170条腿的静脉造影结果直接进行比较。纤维蛋白原摄取试验的假阳性率较高(30%),这与膝关节积液或静脉曲张的存在有关,但与手术部位无关。假阴性率较低(小于5%),以这种方式使用的纤维蛋白原摄取试验可能无法检测出伤口区域中可能由手术局部创伤产生的一部分小血栓。认为纤维蛋白原摄取试验可作为髋关节置换术后深静脉血栓形成的筛查试验用于临床,但为了准确性需要进行静脉造影。